TEI-8362

N/A

Report date: 2023/06/14 09:12:40

Base Information

Drug NameTEI-8362
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeijin Pharma
Active IndicationsN/A
Inactive IndicationsAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A